Proove Bioscience

Quote







anonymous said:
Brian Meshkin is a self righteous con man. A snake that has no true friend except money and the biggest hypocrite in the world. He is never wrong, and never takes responsibility for his bad behavior. No self criticism, it's always other people's fault. This guy needs help. You stole from employees, defrauded many sales reps and billed private insurance companies and the government falsely.

Proove as a biotech company had no reason to exist but for the dysfunctional healthcare system we have in this country. It was a crooked company run by a thief and bunch of incompetent managers and executives that would never be hired for a similar position by a competitor company.

Get over the blame spreading Meshkin and look yourself in the mirror. You were so arrogant only a few months ago, very disrespectful to employees and people who worked so hard with you to build the company, who never got anything for their contributions.

You prepared your bed Meshkin, lay on it. Stop whining and crying. You look like a fool. Save whatever is left of your dignity and wait for your day in court.
Click to expand...
 

































Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
 



anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
 



anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
Tt
 






anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
 



anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
 






Top Bottom
Back
Quote